Search SciPol

Brought to you by

Opioid PACE Act of 2017 (HR 2063, 115th Congress) Download PDF

  • Government
  • Elected Body
  • Neuroscience

Amends the Controlled Substances Act to require certain training as a condition of registration to prescribe or dispense opioids for the treatment of pain or pain management.

Updated last June 13, 2017
for the 04/06/2017 version of HR 2063.
What it does 

HR 2063, the Opioid Preventing Abuse through Continuing Education (PACE) Act of 2017, would amend the Controlled Substances Act (21 U.S.C. 801 et seq.) to require certain health practitioners who describe or dispense opioids for pain treatment or management to undergo a minimum of 12 hours of training every 3 years in regards to:

  • Pain management treatment guidelines and best practices;
  • Early detection of opioid addiction; and
  • Treating and managing opioid-dependent patients.

Such training must be provided by any professional organization listed in the bill's text or determined to be appropriate by the Department of Health and Human Services. The same Department may work any of these organizations to create training modules to be used as part of the 12-hour training requirement.

Excluded from this training requirement are health practitioners defined as hospitals, pharmacies, pharmacists, and veterinarians.


HR 2063 was introduced in the House on April 6, 2017, and on the same day referred to the Committee on Energy and Commerce and the Committee on the Judiciary. It was referred to the Energy and Commerce Subcommittee on Health on April 7, 2017, and to the Judiciary Subcommittee on Crime, Terrorism, Homeland Security, and Investigations on May 1, 2017. 

Creative Commons License This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Please distribute widely but give credit to Duke SciPol and the primary author(s) listed above, linking back to this page if possible.